organon

How do we change our world within us and find peace? Join Dr. Caroline in discussion of what it means to grow and change. Through 30 years of 1000's of clients, Dr. Walrad shares truths she discovered about the spirit, negativity, new, joy, love, compassion and loss and feeling joyfully well. Dr. Walrad talks of information from Samuel Hahnemann's book, ORGANON.  Speaking about our human DNA and emotions come from Gregg Brayden's research. 

Standard Process Whole Food Supplements, Organically Grown in the United States. "Changing lives since 1929"
Order directly from Standard Process here:
carolinewalrad.standardprocess.com/products

On May 12, 2015, Geralyn Ritter, Senior Vice President at pharmaceutical company Merck, was flung from her train car in Amtrak’s deadliest train derailment since 1987. Of 238 passengers, over 200 people were injured and eight were tragically killed. Geralyn was the most critically injured of those who survived.

It took just seconds for Geralyn to go from being a senior executive at one of America’s largest companies to an immobilized ICU patient facing an uncertain future. Despite intense pain, years of recovery, and a continuing struggle with trauma, Geralyn came to view her situation as an act of grace – an undeserved, unmerited gift – that empowered her to rebuild her body and re-establish her career, “bone by bone.”

We invited Geralyn Ritter, now Executive Vice President of External Affairs, ESG, and Sustainability at Organon, a new women’s health organization and spinoff from Merck, to talk about her recovery and return to work through the lens of gratitude, grief, resilience, and, of course, purpose. 

Listen for more insights on:

• Servant leadership and its transformative impact on employees.
• How to balance realism and optimism – both at work and in life.
• Why being open to new solutions and opportunities can improve your resilience in new and challenging situations.

Resources + Links:

• Geralyn Ritter’s LinkedIn
• Bone by Bone
• Merck for Mothers
• Organon
• Why You Don’t Need a Dedicated ESG Strategy

• (00:00) - Welcome to Purpose 360
• (00:13) - Geralyn Ritter
• (03:13) - Meet Geralyn
• (05:42) - Scale and Impact
• (06:24) - Her Role at Merck
• (11:50) - Outcomes
• (13:20) - The Crash
• (16:10) - The Book
• (17:54) - Reslience
• (20:50) - Dealing With the Pain
• (24:34) - Applying Lessons to Work
• (29:25) - Organon
• (34:30) - God's Reason
• (35:56) - New Purpose Perspective
• (36:57) - Goals for Organon
• (38:50) - Servant Leadership
• (41:08) - Advice for Leaders
• (42:43) - Advice When Going Through Trauma
• (45:10) - Final Thoughts
• (45:42) - Wrap Up

Podcast topics:

- Lund talks about her position at pharmaceutical company Organon, which spun off from Merck in June, how Organon positions itself to address an industry deficit in women-centric healthcare, what’s next for Organon and more;

- Discussing longtime Weber Shandwick chairman Jack Leslie’s decision to step down in March 2022 after more than two decades in the role and his history in the industry;

- On Facebook’s financial results and the series of scandals that have put the social media giant on its back foot including leaks that indicated its content might contribute to negative health outcomes for women;

- Discussing Publicis Groupe’s strong performance results that leapfrogged the holding company ahead of Omnicom and WPP to become the world’s most valuable agency group by stock market value and the future of holding companies in general;

- On the consolidation of several Havas PR Global Collective PR functions under the Red Havas network;

- Get vaxxed or get out? Why agencies are increasingly likely to require all employees to disclose their vaccination status as a term of employment;

- What to expect at COP26, the global climate change summit.

Follow us: @PRWeekUS

Receive the latest industry news, insights, and special reports. Start Your Free 1-Month Trial Subscription To PRWeek

Eu conversei com Ricardo Lourenço que é o atual Managing Director da Organon que chega ao mercado para trazer uma visão centralizada na saúde feminina.

Ricardo conta um pouco da sua história e dos valores da Organon e como ela pretende se posicionar no mercado farmacêutica.

Para quem não conhece, a Organon terá três pilares de atuação: Saúde da Mulher, Biossimilares e produtos estabelecidos.

#viaoral

Obrigado por ouvir, acesse @viaoral ou nosso site viaoral.com.br